1. Analysis of mutant allele fractions in driver genes in colorectal cancer – biological and clinical insights. Issue 9 (20th July 2017) Authors: Dienstmann, Rodrigo; Elez, Elena; Argiles, Guillem; Matos, Ignacio; Sanz‐Garcia, Enrique; Ortiz, Carolina; Macarulla, Teresa; Capdevila, Jaume; Alsina, Maria; Sauri, Tamara; Verdaguer, Helena; Vilaro, Marta; Ruiz‐Pace, Fiorella; Viaplana, Cristina; Garcia, Ariadna; Landolfi, Stefania; Palmer, Hec... Journal: Molecular oncology Issue: Volume 11:Issue 9(2017) Page Start: 1263 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Axitinib treatment in advanced RAI-resistant differentiated thyroid cancer (DTC) and refractory medullary thyroid cancer (MTC). Issue 4 (October 2017) Authors: Capdevila, Jaume; Trigo, José Manuel; Aller, Javier; Manzano, José Luís; Adrián, Silvia García; Llopis, Carles Zafón; Reig, Òscar; Bohn, Uriel; Cajal, Teresa Ramón y; Duran-Poveda, Manuel; Astorga, Beatriz González; López-Alfonso, Ana; Martínez, Javier Medina; Porras, Ignacio; Reina, Juan Jose; P... Journal: European journal of endocrinology Issue: Volume 177:Issue 4(2017) Page Start: 309 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Capecitabine and temozolomide in grade 1/2 neuroendocrine tumors: a Spanish multicenter experience. (March 2017) Authors: Crespo, Guillermo; Jiménez-Fonseca, Paula; Custodio, Ana; López, Carlos; Carmona-Bayonas, Alberto; Alonso, Vicente; Navarro, Miguel; Aller, Javier; Sevilla, Isabel; Grande, Enrique; Gajate, Pablo; Alonso-Gordoa, Teresa; Matos, Ignacio; Capdevila, Jaume; Nieto, Beatriz; Barriuso, Jorge Journal: Future oncology Issue: Volume 13:Number 7(2017) Page Start: 615 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Efficacy and safety of pembrolizumab in patients with advanced mesothelioma in the open-label, single-arm, phase 2 KEYNOTE-158 study. Issue 6 (June 2021) Authors: Yap, Timothy A; Nakagawa, Kazuhiko; Fujimoto, Nobukazu; Kuribayashi, Kozo; Guren, Tormod Kyrre; Calabrò, Luana; Shapira-Frommer, Ronnie; Gao, Bo; Kao, Steven; Matos, Ignacio; Planchard, David; Chatterjee, Arkendu; Jin, Fan; Norwood, Kevin; Kindler, Hedy L Journal: Lancet Issue: Volume 9:Issue 6(2021) Page Start: 613 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Emerging tyrosine kinase inhibitors for the treatment of metastatic colorectal cancer. (2nd July 2016) Authors: Matos, Ignacio; Elez, Elena; Capdevila, Jaume; Tabernero, Josep Journal: Expert opinion on emerging drugs Issue: Volume 21:Number 3(2016:Sep.) Page Start: 267 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Lenvatinib in Patients With Advanced Grade 1/2 Pancreatic and Gastrointestinal Neuroendocrine Tumors: Results of the Phase II TALENT Trial (GETNE1509). Issue 20 (10th July 2021) Authors: Capdevila, Jaume; Fazio, Nicola; Lopez, Carlos; Teulé, Alexandre; Valle, Juan W.; Tafuto, Salvatore; Custodio, Ana; Reed, Nicholas; Raderer, Markus; Grande, Enrique; Garcia-Carbonero, Rocio; Jimenez-Fonseca, Paula; Hernando, Jorge; Bongiovanni, Alberto; Spada, Francesca; Alonso, Vicente; Antonuzz... Journal: Journal of clinical oncology Issue: Volume 39:Issue 20(2021) Page Start: 2304 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Phase II Study of Everolimus and Octreotide LAR in Patients with Nonfunctioning Gastrointestinal Neuroendocrine Tumors: The GETNE1003_EVERLAR Study. (23rd May 2018) Authors: Capdevila, Jaume; Teulé, Alexandre; Barriuso, Jorge; Castellano, Daniel; Lopez, Carlos; Manzano, Jose Luis; Alonso, Vicente; García‐Carbonero, Rocío; Dotor, Emma; Matos, Ignacio; Custodio, Ana; Casanovas, Oriol; Salazar, Ramon Journal: Oncologist Issue: Volume 24:Number 1(2019) Page Start: 38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Pralsetinib for patients with advanced or metastatic RET-altered thyroid cancer (ARROW): a multi-cohort, open-label, registrational, phase 1/2 study. Issue 8 (August 2021) Authors: Subbiah, Vivek; Hu, Mimi I; Wirth, Lori J; Schuler, Martin; Mansfield, Aaron S; Curigliano, Giuseppe; Brose, Marcia S; Zhu, Viola W; Leboulleux, Sophie; Bowles, Daniel W; Baik, Christina S; Adkins, Douglas; Keam, Bhumsuk; Matos, Ignacio; Garralda, Elena; Gainor, Justin F; Lopes, Gilberto; Lin, Ch... Journal: Lancet Issue: Volume 9:Issue 8(2021) Page Start: 491 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. The PALBONET Trial: A Phase II Study of Palbociclib in Metastatic Grade 1 and 2 Pancreatic Neuroendocrine Tumors (GETNE‐1407). (11th February 2020) Authors: Grande, Enrique; Teulé, Alex; Alonso‐Gordoa, Teresa; Jiménez‐Fonseca, Paula; Benavent, Marta; Capdevila, Jaume; Custodio, Ana; Vera, Ruth; Munarriz, Javier; La Casta, Adelaida; Díez, Juan José; Gajate, Pablo; Molina‐Cerrillo, Javier; Matos, Ignacio; Cristóbal, Eva María; Ruffinelli, José C.; Pala... Journal: Oncologist Issue: Volume 25:Number 9(2020) Page Start: 745 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. The safety of ramucirumab for the treatment of colorectal cancer. Issue 9 (2nd September 2018) Authors: Noguerido, Alba; Mulet-Margalef, Núria; Matos, Ignacio; Ros, Javier; Argilés, Guillem; Élez, Elena; Tabernero, Josep Journal: Expert opinion on drug safety Issue: Volume 17:Issue 9(2018) Page Start: 945 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗